Blood plasma phosphorylated-tau isoforms track CNS change in Alzheimer’s disease

Highly sensitive and specific plasma biomarkers for Alzheimer’s disease (AD) have the potential to improve diagnostic accuracy in the clinic and facilitate research studies including enrollment in prevention and treatment trials. We recently reported CSF tau hyperphosphorylation, especially on T217,...

Descripción completa

Detalles Bibliográficos
Autores principales: Barthélemy, Nicolas R., Horie, Kanta, Sato, Chihiro, Bateman, Randall J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Rockefeller University Press 2020
Materias:
Brief Definitive Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7596823/
https://www.ncbi.nlm.nih.gov/pubmed/32725127
http://dx.doi.org/10.1084/jem.20200861

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7596823/
https://www.ncbi.nlm.nih.gov/pubmed/32725127
http://dx.doi.org/10.1084/jem.20200861

Ejemplares similares